H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership collaboration with Otsuka Pharmaceuticals Co., Ltd.; and collaboration with FeetMe focusing on the use of sensor shoe soles. H. Lundbeck A/S also has a collaboration with Alloy Therapeutics, Inc. for the discovery of novel biologics therapies. The company was founded in 1915 and is headquartered in Valby, Denmark.
H. Lundbeck Dividend Announcement
• H. Lundbeck announced a annually dividend of kr0.70 per ordinary share which will be made payable on . Ex dividend date: 2024-03-21
• H. Lundbeck annual dividend for 2024 was kr0.70
• H. Lundbeck annual dividend for 2023 was kr0.58
• H. Lundbeck's trailing twelve-month (TTM) dividend yield is 1.62%
• H. Lundbeck's payout ratio for the trailing twelve months (TTM) is 25.83%
H. Lundbeck Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-03-21 | kr0.70 | annually | |
2023-03-22 | kr0.58 | annually | 2023-03-24 |
H. Lundbeck Dividend per year
H. Lundbeck Dividend Yield
H. Lundbeck current trailing twelve-month (TTM) dividend yield is 1.62%. Interested in purchasing H. Lundbeck stock? Use our calculator to estimate your expected dividend yield:
H. Lundbeck Financial Ratios
H. Lundbeck Dividend FAQ
1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.
2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.
3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.
4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.
5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Place an order: Use the brokerage's trading platform to place an order to buy H. Lundbeck stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.